Khorana risk score and PROTECHT risk score as prediction models of venous thromboembolism in cancer outpatients receiving chemotherapy: a retrospective analysis

被引：0
|
作者：
Barni, S. [1 ]
Labianca, R. [2 ]
Verso, M. [3 ]
Gasparini, G. [4 ]
Bonizzoni, E. [5 ]
Mandala, M. [2 ]
Brighenti, M. [6 ]
Petrelli, F. [1 ]
Bianchini, C. [7 ]
Perrone, T. [7 ]
Agnelli, G. [3 ]
机构：
[1] Treviglio Hosp, Med Oncol Dept, Treviglio, Italy
[2] Osped Riuniti Bergamo, Med Oncol Unit, Oncol & Hematol Dept, I-24100 Bergamo, Italy
[3] Univ Perugia, Internal & Vasc Med Stroke Unit, I-06100 Perugia, Italy
[4] San Filippo Neri Hosp, Dept Oncol, Rome, Italy
[5] Univ Milan, Inst Med Stat & Biometry, I-20122 Milan, Italy
[6] Cremona Hosp, Med Oncol Dept, Cremona, Italy
[7] Italfarmaco SpA, Dept Sci, Cinisello Balsamo, Italy
来源：
THROMBOSIS RESEARCH | 2012年 / 129卷
关键词：
D O I：
10.1016/S0049-3848(12)70061-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [41] Khorana risk score: Is the body mass index a predictable factor for thromboembolism in European countries? A retrospective analysis.
    Barni, Sandro
    Labianca, Roberto
    Verso, Melina
    Gasparini, Giampietro
    Bonizzoni, Erminio
    Mandala, Mario
    Brighenti, Matteo
    Petrelli, Fausto
    Bianchini, Carlo
    Perrone, Tania
    Agnelli, Giancarlo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Incidence of venous thromboembolism and Khorana score in patients with sarcoma: a retrospective study in a single institution
    Figaredo Berjano, C.
    Zumarraga Cuesta, A.
    Sala Gonzalez, M. A.
    de San Vicente Hernandez, B. Lopez
    Nuno Escolastico, M.
    Galve Calvo, E.
    Martinez del Prado, M. P.
    THROMBOSIS RESEARCH, 2021, 200 : S62 - S63
  • [43] Performance of Khorana Score to Predict One-Year Risk of Venous Thromboembolism in over Two Million Patients with Cancer
    Arafah, Yasmin
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Nayak, Lalitha V.
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [44] Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy
    Tera, Yousra
    Suh, Yoon Jin
    Fainchtein, Karina
    Agrawal, Anita
    Mates, Mihaela
    Othman, Maha
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 : S19 - S27
  • [45] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)
    Franco Moreno, A. I.
    Garcia Navarro, M. J.
    Ortiz Sanchez, J.
    Martin Diaz, R. M.
    Madronal Cerezo, E.
    de Ancos Aracil, C. L.
    Cabello Clotet, N.
    Perales Fraile, I.
    Gimeno Garcia, S.
    Montero Hernandez, C.
    Zapatero Gaviria, A.
    Ruiz Giardin, J. M.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 29 : 59 - 64
  • [46] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (damoves)
    Moreno, A. I. F.
    Navarro, M. J. G.
    Sanchez, J. O.
    Diaz, R. M. M.
    Cerezo, E. M.
    de Ancos Aracil, C. L.
    Diaz, V. M.
    Garcia, A. G.
    Hernandez, C. M.
    Arponen, S.
    Clotet, N. C.
    Giardin, J. M. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 682 - 682
  • [47] Venous thromboembolism in cancer outpatients receiving chemotherapy for solid tumors
    Font, C.
    Farrus, B.
    Vidal, L.
    Ortega, V.
    Campayo, M.
    Tassies, D.
    Reverter, J. C.
    Gascon, P.
    THROMBOSIS RESEARCH, 2010, 125 : S168 - S168
  • [48] Comparison of venous thromboembolism risk assessment models in patients receiving chemotherapy
    Talasiewicz, K.
    Ozdowska, P.
    Milanowska, B.
    Gepner, K.
    Jagielska, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [49] External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model
    Spyropoulos, Alex C.
    Eldredge, Joanna B.
    Anand, Lalitha N.
    Zhang, Meng
    Qiu, Michael
    Nourabadi, Soheila
    Rosenberg, David J.
    ONCOLOGIST, 2020, 25 (07): : E1083 - E1090
  • [50] Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
    Sandro Barni
    Roberto Labianca
    Giancarlo Agnelli
    Erminio Bonizzoni
    Melina Verso
    Mario Mandalà
    Matteo Brighenti
    Fausto Petrelli
    Carlo Bianchini
    Tania Perrone
    Giampietro Gasparini
    Journal of Translational Medicine, 9
12345